Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - JUNIPER PHARMACEUTICALS INC | Financial_Report.xls |
| 10-K - FORM 10-K - JUNIPER PHARMACEUTICALS INC | d849346d10k.htm |
| EX-21 - EX-21 - JUNIPER PHARMACEUTICALS INC | d849346dex21.htm |
| EX-31.1 - EX-31.1 - JUNIPER PHARMACEUTICALS INC | d849346dex311.htm |
| EX-32.1 - EX-32.1 - JUNIPER PHARMACEUTICALS INC | d849346dex321.htm |
| EX-31.2 - EX-31.2 - JUNIPER PHARMACEUTICALS INC | d849346dex312.htm |
| EX-32.2 - EX-32.2 - JUNIPER PHARMACEUTICALS INC | d849346dex322.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
Columbia Laboratories, Inc.
Boston, MA
We hereby consent to the incorporation by reference in the Registration Statement on Forms S-3 (No. 333-169599, 333-75275, 333-125671, 333-132803, 333-140107, 333-37976, 333-38230, and 333-155530) and Forms S-8 (No. 333-34079, 333-63470, 333-116072, 333-152008, and 333-188647) of Columbia Laboratories, Inc. of our report dated March 18, 2015, relating to the consolidated financial statements which appears in this Annual Report on Form 10-K.
/s/ BDO USA, LLP
Boston, MA
March 18, 2015